Skip to content
Screener

Natera, Inc. NTRA Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$16M+23.1%
NeoGenomics logo
NeoGenomicsNEO
$2.09M+277%
Illumina logo
IlluminaILMN
$24M-11.1%
CareDx logo
CareDxCDNA
$109K-96.4%
Veracyte logo
VeracyteVCYT
$2.74M-7.8%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$5.03M-7.8%

Other financials

Income statement

See full
Revenue$752.8M+37.7%
Operating income-$75.8M+31.3%
Net income-$67.0M+33.7%
EPS (diluted)-$0.47+36.5%

Balance sheet

See full
Cash & equivalents$1.1B+9.1%
Total debt$238.5M+21.6%
Total equity$1.8B+46.2%
Total assets$2.7B+51.2%

Cash flow

See full
Operating cash flow$54.8M+45.8%
CapEx$63.4M+145%
Free cash flow$18.0M-20.3%

Valuation

See full
Market cap$39.33B+102%
Enterprise value$38.48B+106%
P/S14.5×+4.6×

Profitability

See full
Gross margin42.9%
Operating margin-10.7%-2.4pp
Net margin-14.6%+0.6pp
FCF margin4.2%-0.5pp

Returns & leverage

See full
Return on equity-29%+4.1pp
Debt / equity0.1×0.0×
Current ratio-0.7×

Where this comes from

Reported directly by Natera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The source filing: Natera, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054525
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Investment in related party(10,000)
Net cash used in investing activities(95,566)(40,712)
Financing activities
Proceeds from exercise of stock options4,736884
Cash paid to satisfy statutory withholding requirement for net settlement of cashless stock option exercises(5,097)
Proceeds from the issuance of common stock under the employee stock purchase plan16,43012,236
Stock issuance costs(105)
Net cash provided by financing activities15,96413,120

Item 1. Financial Statements (unaudited)

FAQ

What is Natera, Inc.'s stock issuance proceeds?
Natera, Inc. (NTRA) reported stock issuance proceeds of $873K in Q2 2026.
How has Natera, Inc.'s stock issuance proceeds changed year-over-year?
Natera, Inc.'s stock issuance proceeds increased by 156.8% year-over-year, from $340K to $873K.
What is the long-term trend for Natera, Inc.'s stock issuance proceeds?
Over 4 years (2021 to 2025), Natera, Inc.'s stock issuance proceeds has grown at a 17.5% compound annual growth rate (CAGR), from $11.82M to $22.54M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Ask your AI about Natera, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude